Zoetis (ZTS) Capital Expenditures (2012 - 2026)

Zoetis' (ZTS) quarterly Capital Expenditures came in at $110.0 million in Q1 2026, down 38.2% year-on-year from $178.0 million in Q1 2025, and down 82.2% on a QoQ basis from $618.0 million in Q4 2025.

Zoetis (ZTS) Capital Expenditures (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Capital Expenditures data on file, last reported at $110.0 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 38.2% year-over-year to $110.0 million in Q1 2026; TTM through Mar 2026 was $553.0 million, a 1248.78% increase from a year earlier, with the FY2025 full-year figure at $621.0 million, up 20600.0% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $110.0 million, down from $618.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for ZTS reached as high as $618.0 million in Q4 2025 and fell as low as -$385.0 million in Q3 2023.
  • Historically, Capital Expenditures has averaged $82.6 million across 5 years, with a median of $3.5 million in 2022.
  • On a YoY basis, Capital Expenditures climbed as much as 61900.0% in 2025 and fell as far as 32500.0% in 2025.
  • Year by year, Capital Expenditures stood at $581.0 million in 2022, then sank by 100.34% to -$2.0 million in 2023, then soared by 50.0% to -$1.0 million in 2024, then soared by 61900.0% to $618.0 million in 2025, then plunged by 82.2% to $110.0 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $110.0 million in Q1 2026, $618.0 million in Q4 2025, and -$324.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 10.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 110.00 Mn
Mar 31, 2026 110.00 Mn
Dec 31, 2025 618.00 Mn
Dec 31, 2025 618.00 Mn
Sep 30, 2025 -324.00 Mn
Sep 30, 2025 -324.00 Mn
Jun 30, 2025 149.00 Mn
Jun 30, 2025 149.00 Mn
Mar 31, 2025 178.00 Mn
Mar 31, 2025 178.00 Mn
Dec 31, 2024 -1.00 Mn
Dec 31, 2024 -1.00 Mn
Sep 30, 2024 1.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 -137.00 Mn
Jun 30, 2024 -137.00 Mn
Mar 31, 2024 140.00 Mn
Mar 31, 2024 140.00 Mn
Dec 31, 2023 -2.00 Mn
Dec 31, 2023 -2.00 Mn